Press Release: ProtonMedia and PPD to Introduce New Virtual Clinical Trial Training Solution
LANSDALE, Pa., and WILMINGTON, N.C.—ProtonMedia and PPD, Inc. today announced they have entered into an agreement to jointly develop a new virtual clinical trial training solution that will improve the cost effectiveness, speed and quality of clinical trial training for life sciences organizations.
The solution will integrate ProtonMedia’s ProtoSphere virtual collaboration environment with PPD® Adaptive Solutions, PPD’s innovative suite of data and information technology solutions. The combination will be a virtual collaborative environment built around PPD’s customizable, flexible and integrated technology solutions to advance clinical research programs. PPD will showcase ProtoSphere to its client base at the 20th Annual Partnerships in Clinical Trials conference being held March 30 to April 1 in Phoenix, Ariz.
“A crucial step to enhancing the quality of site management and clinical monitoring is to improve the way we train clinical research associates to monitor clinical trials,†said Mike Wilkinson, Ph.D., executive vice president and chief information officer for PPD. “ProtonMedia is the ideal virtual collaboration technology provider because of ProtoSphere’s strong ability to integrate rapidly with our solutions, and ProtonMedia’s commitment to Microsoft Corp. technologies, which are pervasive across life sciences companies today.â€
ProtoSphere is the only virtual collaboration environment built with Microsoft technology and is one of the leading virtual collaboration environments in the area of life sciences.
“Nearly every life sciences organization is re-evaluating their clinical trial training processes, looking for better ways to reduce costs and meet increasingly stringent regulatory requirements,†says Ron Burns, CEO of ProtonMedia. “Working with PPD, we will be able to help address some of these tremendous pain points facing the life sciences industry.â€
“This partnership between ProtonMedia and PPD is an example of two organizations coming together in a way that has great synergy for Microsoft’s Life Sciences customers,†says Les Jordan, chief technology strategist, Microsoft Life Sciences. “The integration of ProtoSphere and PPD Adaptive Solutions will help to deliver a positive impact to life sciences organizations seeking to create a more collaborative and cost-effective R&D framework.â€
Conference participants can visit PPD at Booth No. 601 for a demonstration of ProtonMedia’s ProtoSphere clinical trial training solution.
ABOUT PROTONMEDIA
ProtonMedia is the developer of ProtoSphere, the market-leading virtual collaboration environment for the high-performance workplace, and the #1 virtual environment for collaborative PLM in life sciences. ProtoSphere’s virtual environment provides an arsenal of business-focused collaboration and communication tools that help companies accelerate decision-making and raise productivity, improving workplace performance overall. The company is a Gartner “Cool Vendor in the High-Performance Workplace†for 2010. Its customers include some of the world’s most respected brands. A trial version of ProtoSphere can be downloaded at http://protonmedia.com/trial-download/. For more information, visit www.ProtonMedia.com.
ABOUT PPD
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.
- Breaking news: Philip Rosedale to speak at OSCC on Sunday - December 7, 2024
- Registration now open for December’s OpenSim Community Conference - November 13, 2024
- OpenSim Worlds Fair will be held in March - November 12, 2024